CancerIQ Blog

Mathew Knowles - Beyonce Knowles' father - revealed on Good Morning America that he is battling breast cancer, which was caused by a pathogenic BRCA2 mutation. The news coincided with …

In part one of our three-part webinar series, we explored the enormous value proposition that cancer risk assessment, genetic counseling, and genetic testing present to health systems. Now, we highlight …

In a 2018 study, researchers tested the efficacy of the Tyrer-Cuzick Lifetime risk model for identifying women at increased or high risk of hereditary breast cancer. In doing so, 100,318 …

Breast imaging centers are a hub for screening and early detection. They play an important role in identifying high-risk patients prior to a cancer diagnosis. We covered this in the …

The U.S. Preventive Services Task Force (USPSTF) recently updated its recommendations to include more women for BRCA screening. Receiving less attention from that announcement was the recommendation that primary care …

Primary care clinicians should assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with BRCA1 and BRCA2 gene …

There are over 157 million women in the United States. About 12 percent of those women will develop invasive breast cancer, according to the nonprofit group BreastCancer.org. That's over 18 …

How do health systems make the most of their valuable - and limited - genetic counselor resources? This was the focus of the recent "Hot Topic Webinar" hosted by the …

The stats are well-known by now. The U.S. spends nearly 18 percent of its GDP on healthcare, which is about twice that of other high-income nations. However, despite the amount …

Hereditary cancer risk assessment programs present an enormous value proposition for health systems. In the short-term, it can drive additional revenue through increased surveillance and preventative services. Over the long …